Year 2020 / Volume 112 / Number 3
Review
Mechanism of bariatric and metabolic surgery: beyond surgeons, gastroenterologists and endocrinologists

229-233

DOI: 10.17235/reed.2020.6925/2020

Víctor Valentí, Javier A. Cienfuegos, Sara Becerril Mañas, Gema Frühbeck,

Abstract
Bariatric-metabolic surgery is the safest, most effective and long-lasting treatment for obesity and its associated co-morbidities, whether they be metabolic (type 2 diabetes, hyperlipidemia non-alcoholic fatty liver disease) or cardiovascular (myocardial infarction, stroke). Due to the obesity pandemic, bariatric-metabolic surgery is the second most frequent intra-abdominal procedure and the gastroenterologist and the surgeon must be aware of the physiologic changes caused by the anatomic reconfiguration following surgery. Among the mechanisms of action, independent of the loss of weight and fat tissue, surgery leads to the release of gut hormones related to carbohydrate metabolism (the rapid and continuous release of insulin), appetite and degree of satiety (glucagon-like peptide 1, peptide Y-Y, grhelin). As a result, indications for surgery have been extended to earlier disease stages. Apart from the neurohormonal effects, changes in the metabolism of biliary acids and the microbiota have also been reported. The aim of this review is to describe the physiologic changes caused by bariatric-metabolic surgery.
Share Button
New comment
Comments

04/09/2022 9:45:59
?


References
1. Afshin A, Forouzanfar MH, Reitsma MB, et al. Health effects of overweight and obesity in 195 countries over 25 years. N Engl J Med. 2017;377(1):13–27.
2. Gutiérrez-Fisac JL, Guallar-Castillón P, León-Muñoz LM, et al. Prevalence of general and abdominal obesity in the adult population of Spain, 2008-2010: the ENRICA study. Obes Rev. 2012 ;13(4):388–92. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22151906
3. Frühbeck G. Bariatric and metabolic surgery: a shift in eligibility and success criteria. Nat Rev Endocrinol. 2015;11(8):465–77. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26055046
4. Catalán V, Gómez-Ambrosi J, Rodríguez A, et al. Adipose tissue immunity and cancer. Front Physiol. 2013;202;4:275. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24106481
5. Hotamisligil GS. Inflammation, metaflammation and immunometabolic disorders. Vol. 542, Nature. Nature Publishing Group; 2017. p. 177–85.
6. Zhang C, Zhang J, Liu Z, et al. More than an Anti-diabetic Bariatric Surgery, Metabolic Surgery Alleviates Systemic and Local Inflammation in Obesity. Obes Surg. 2018;28(11):3658–68. Available from: http://www.ncbi.nlm.nih.gov/pubmed/30187424
7. Yarmush ML, D’Alessandro M, Saeidi N. Regulation of Energy Homeostasis After Gastric Bypass Surgery. Annu Rev Biomed Eng. 2017;19(1):459–84.
8. Zhang H, DiBaise JK, Zuccolo A, et al. Human gut microbiota in obesity and after gastric bypass. Proc Natl Acad Sci U S A. 2009;106(7):2365–70.
9. Tilg H, Zmora N, Adolph TE, et al. The intestinal microbiota fuelling metabolic inflammation. Nat Rev Immunol. 2020 ;20(1):40–54. Available from: http://www.ncbi.nlm.nih.gov/pubmed/31388093
10. Gómez-Ambrosi J, Moncada R, Valentí V, et al. Cardiometabolic Profile Related to Body Adiposity Identifies Patients Eligible for Bariatric Surgery More Accurately than BMI. Obes Surg. 2015;25(9):1594-1603.
11. Camilleri M, Malhi H, Acosta A. Gastrointestinal Complications of Obesity. Gastroenterology. 2017;152(7):1656–70. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28192107
12. Schauer PR, Bhatt DL, Kirwan JP, et al. Bariatric Surgery versus Intensive Medical Therapy for Diabetes - 5-Year Outcomes. N Engl J Med . 2017;376(7):641–51. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28199805
13. Nguyen NT, Varela JE. Bariatric surgery for obesity and metabolic disorders: state of the art. Nat Rev Gastroenterol Hepatol. 2017;14(3):160–9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27899816
14. Espinet Coll E, López-Nava Breviere G, Nebreda Durán J, et al. Spanish Consensus Document on Bariatric Endoscopy. Part 1. General considerations. Rev Esp Enferm Dig 2018 ;110(6):386–99. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29766736
15. Espinet Coll E, López-Nava Breviere G, Nebreda Durán J, et al. Spanish consensus document on bariatric endoscopy. Part 2: specific endoscopic treatments. Rev Esp Enferm Dig 2019 ;111(2):140–54. Available from: http://www.ncbi.nlm.nih.gov/pubmed/30654612
16. Drucker DJ. Deciphering metabolic messages from the gut drives therapeutic innovation: the 2014 Banting Lecture. Diabetes. 2015;64(2):317–26.
17. Primeaux SD, de Silva T, Tzeng TH, et al. Recent advances in the modification of taste and food preferences following bariatric surgery. Rev Endocr Metab Disord. 2016;17(2):195–207. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27245858
18. Bhandari M, Fobi MAL, Buchwald JN, et al. Standardization of Bariatric Metabolic Procedures: World Consensus Meeting Statement. Obes Surg. 2019;29(Suppl 4):309–45. Available from: http://www.ncbi.nlm.nih.gov/pubmed/31297742
19. Evers SS, Sandoval DA, Seeley RJ. The Physiology and Molecular Underpinnings of the Effects of Bariatric Surgery on Obesity and Diabetes. Annu Rev Physiol. 2017;79:313–34. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27912678
20. Mason BL, Wang Q, Zigman JM. The central nervous system sites mediating the orexigenic actions of ghrelin. Annu Rev Physiol. 2014;76:519–33.
21. Frühbeck G, Diez-Caballero A, Gil MJ, et al. The decrease in plasma ghrelin concentrations following bariatric surgery depends on the functional integrity of the fundus. Obes Surg. 2004;14(5):606-612
22. Manning S, Batterham RL. The role of gut hormone peptide YY in energy and glucose homeostasis: twelve years on. Annu Rev Physiol. 2014;76:585–608.
23. Stefater MA, Wilson-Pérez HE, Chambers AP, et al. All bariatric surgeries are not created equal: insights from mechanistic comparisons. Endocr Rev. 2012;33(4):595–622. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22550271
24. Olbers T, Björkman S, Lindroos A, et al. Body composition, dietary intake, and energy expenditure after laparoscopic Roux-en-Y gastric bypass and laparoscopic vertical banded gastroplasty: A randomized clinical trial. Ann Surg. 2006;244(5):715–22.
25. Gómez-Ambrosi J, Catalán V, Rodríguez A, et al. Increased cardiometabolic risk factors and inflammation in adipose tissue in obese subjects classified as metabolically healthy. Diabetes Care. 2014;37(10):2813–21. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25011950
Related articles

Original

Usefulness of an intra-gastric balloon before bariatric surgery

DOI: 10.17235/reed.2017.4624/2016

Citation tools
Valentí V, Cienfuegos J, Becerril Mañas S, Frühbeck G. Mechanism of bariatric and metabolic surgery: beyond surgeons, gastroenterologists and endocrinologists. 6925/2020


Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Metrics
This article has received 2565 visits.
This article has been downloaded 501 times.

Statistics from Dimensions


Statistics from Plum Analytics

Publication history

Received: 31/01/2020

Accepted: 31/01/2020

Online First: 21/02/2020

Published: 05/03/2020

Article Online First time: 21 days

Article editing time: 34 days


Share
This article hasn't been rated yet.
Reader rating:
Valora este artículo:




Asociación Española de Ecografía Digestiva Sociedad Española de Endoscopia Digestiva Sociedad Española de Patología Digestiva
The Spanish Journal of Gastroenterology is the official organ of the Sociedad Española de Patología Digestiva, the Sociedad Española de Endoscopia Digestiva and the Asociación Española de Ecografía Digestiva
Cookie policy Privacy Policy Legal Notice © Copyright 2023 y Creative Commons. The Spanish Journal of Gastroenterology